Northwest Biotherapeutics (NWBO) Revenue (2010 - 2026)
Northwest Biotherapeutics (NWBO) posted quarterly Revenue of $494000.0 for Q1 2026, up 31.73% year-over-year from $375000.0 in Q1 2025, and down 26.49% quarter-over-quarter from $672000.0 in Q4 2025.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Revenue (2010 - 2026) Analysis & Trends
Northwest Biotherapeutics' Revenue history runs 17 years deep, the most recent figure standing at $494000.0 for Q1 2026.
- In Q1 2026, Revenue rose 31.73% year-over-year to $494000.0; the TTM figure through Mar 2026 stood at $1.5 million (up 1.63% YoY), while the FY2025 annual figure was $1.4 million, changed 0.29% from the prior year.
- Revenue for Q1 2026 stood at $494000.0, down from $672000.0 in the prior quarter.
- The five-year high for Revenue was $880000.0 in Q1 2023, with the low at $131000.0 in Q2 2025.
- The 5-year median for Revenue is $403000.0 (2022), against an average of $404058.8.
- Peak annual rise in Revenue reached 190.91% in 2025, while the deepest fall reached 74.31% in 2025.
- Northwest Biotherapeutics' Revenue stood at $597000.0 in 2022, then decreased by 25.46% to $445000.0 in 2023, then slumped by 48.09% to $231000.0 in 2024, then surged by 190.91% to $672000.0 in 2025, then decreased by 26.49% to $494000.0 in 2026.
- Business Quant data shows NWBO's Revenue at $494000.0 in Q1 2026, $672000.0 in Q4 2025, and $200000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Northwest Biotherapeutics | 279.21 Mn | 278.62 Mn | - | 807,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 807,000.00 |
| Mar 31, 2026 | 494,000.00 |
| Dec 31, 2025 | 672,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Mar 31, 2025 | 375,000.00 |
| Dec 31, 2024 | 231,000.00 |
| Sep 30, 2024 | 357,000.00 |
| Jun 30, 2024 | 510,000.00 |
| Mar 31, 2024 | 284,000.00 |
| Dec 31, 2023 | 445,000.00 |
| Sep 30, 2023 | 406,000.00 |
| Jun 30, 2023 | 201,000.00 |
| Mar 31, 2023 | 880,000.00 |
| Dec 31, 2022 | 597,000.00 |
| Sep 30, 2022 | 206,000.00 |
| Jun 30, 2022 | 477,000.00 |
| Mar 31, 2022 | 403,000.00 |
| Sep 30, 2021 | 350,000.00 |
| Jun 30, 2021 | 416,000.00 |